Sign in Pull a receipt

RARE

Ultragenyx Pharmaceutical Inc.

Biotechnology · Biotechnology

$319.14 sample

+0.94 (+0.30%) 1D

Market cap

$783.0B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-21

Alerts

8

Price$319.14 +7.80% 3M daily closessample

327.56294.99

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21SECDEF 14A filed
Oct 14INSInsider sell: EVP, Operations
Oct 06INSInsider buy: Director
Sep 30SECForm 144 filed
Sep 22SECDEF 14A filed
Sep 11INSInsider buy: EVP, Operations
Sep 02INSInsider sell: General Counsel
Aug 26INSInsider sell: Chief Financial Officer

Sign up to see the real RARE record →

Company facts

SEC EDGAR registration

Name: Ultragenyx Pharmaceutical Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in RARE

sample

Insiders: 35 insider transactions over 90 days, net selling, $599.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 35 funds hold $10.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$47.8B +11.3% y/y

Q4 2024Q3 2026

Inventory$30.6B +22.2% y/y

Q4 2024Q3 2026

Accounts receivable$22.9B +20.8% y/y

Q4 2024Q3 2026

Total debt$57.5B +11.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $424.7B -0.8% 3M
Sample peer B: $198.6B -3.4% 3M
Sample peer C: $622.2B -5.0% 3M
Sample peer D: $738.3B -13.3% 3M
Sample peer E: $171.2B -13.1% 3M